ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 51146 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 51146; 2) Community: the network communities that were significantly associated with the response to NSC 51146; 3) Molecule: the relationships between components within communities and NSC 51146; 4) MDR: the compounds that were significantly associated with the NSC 51146.

NSC Compound Enrichment Correlation
NSC 712742 Null 0.0278435641331424 0.15711641
NSC 715559 Null 0.0278435641331424 0.2202017
NSC 744020 methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate 0.0278435641331424 -0.018529504
NSC 746149 N,N'-bis(4-bromo-2-fluorobenzoyl)-L-selenocystine bis(4-methoxyphenacyl) ester hemihydrate 0.0303322639291196 0.076225018
NSC 87500 Solacongestidine 0.0303322639291198 0.10671439
NSC 19441 FDA 0283 0.0337307532806863 0.32936327
NSC 309895 Null 0.0337307532806863 -0.029350418
NSC 49520 o-Tolualdehyde, 4-(bis(2-chloroethyl)amino)- 0.0337307532806863 0.30703387
NSC 711070 Null 0.0337307532806866 -0.104443
NSC 606869 Clofarabine 0.0337307532806868 0.1625837
Total:42  Current:25    [First] [Prev] [Next] [Last]